Skip to main content
. 2012 Jul 11;2012(7):CD002991. doi: 10.1002/14651858.CD002991.pub3

Weir 1999.

Methods Design: parallel group
Randomisation: yes, method not stated
Blinding: double blind, double dummy
Withdrawals: stated
Participants Setting: multicentre study, UK, hospital outpatient clinic
Number eligible: not stated
Number enrolled: 98
Number in treatment group: 49
Number in control group: 49
Number of withdrawals (treatment/control): 39 total
Number completing trial (treatment/control): 59 total
Age range: adult (mean 65.5 yr in intervention group, 67.6 yr in control group
Sex: 73M, 15F
Ethnicity: not stated
COPD diagnosis: clinical diagnosis of COPD, adult onset airflow obstruction , FEV1 <70% predicted, FEV1/FVC <65%
Severity of COPD: Mean pre‐bronchodilator FEV1 39.7% in intervention group, 41.4% in control group
Inclusion criteria: as for COPD diagnosis
Exclusion criteria: clinical diagnosis of asthma (including clinical significant bronchodilator reversibility, acute attacks of breathlessness with recovery between attacks), significant improvement with steroid treatment in the past, steroid treatment clinically indicated, use of steroids >3 month in last 1 yr or during last 4 wk
Baseline characteristics of treatment/control groups: more females in the intervention group
Interventions BDP 750 µg, 2 times a day (1500 µg/d) for weight <50 kg, BDP 1000 µg, 2 times a day (2000 µg/d) for weight >50 kg
Placebo 2 times a day
Metered dose inhaler (identical) via spacer device
2 years
Outcomes Change in pre‐bronchodilator FEV1
 Change in pre‐bronchodilator FVC
 Change in post‐bronchodilator FEV1
 Change in post‐bronchodilator FVC
 PC20 histamine
 Exacerbations
 Dyspnoea index
 CRQ (subgroup)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "randomised". Method not stated
Allocation concealment (selection bias) Unclear risk Information not available
Blinding (performance bias and detection bias) 
 All outcomes Low risk Quote: "double blind"
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Information not available
Selective reporting (reporting bias) Low risk All outcomes reported